Relations among IOP reduction, ocular disposition and pharmacology of the carbonic anhydrase inhibitor ethoxzolamide
Authors:
- Amir Bar-IlanABAmir Bar-Ilan
- 1 July 1992
- journal article
- Published by Elsevier in Experimental Eye Research
- Vol. 55 (1) , 73-79
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Chemical and pharmacological properties of MK-927, a sulfonamide carbonic anhydrase inhibitor that lowers intraocular pressure by the topical routeExperimental Eye Research, 1990
- The determination of osteopetrotic phenotypes by selective inactivation of red cell carbonic anhydrase isoenzymesClinica Chimica Acta, 1985
- Determination of Ethoxzolamide in the Iris/Ciliary Body of the Rabbit Eye by High-Performance Liquid Chromatography: Comparison of Tissue Levels Following Intravenous and Topical AdministrationsJournal of Pharmaceutical Sciences, 1984
- Diurnal and seasonal variations in intraocular pressure in the rabbitExperimental Eye Research, 1984
- Topical carbonic anhydrase inhibitorsJournal of Medicinal Chemistry, 1984
- The transcorneal permeability of sulfonamide carbonic anhydrase inhibitors and their effect on aqueous humor secretionExperimental Eye Research, 1983
- Carbonic anhydrase: chemistry, physiology, and inhibitionPhysiological Reviews, 1967
- The binding of aromatic sulfonamides to erythrocytesBiochemical Pharmacology, 1961
- Sulphonamide Carbonic Anhydrase Inhibitors and Intra‐Ocular Pressure in Rabbits. A comparison between in vitro and in vivo activities based on tissue distributions and physical and chemical properties of nine compounds.Acta Pharmacologica et Toxicologica, 1961
- Studies in detoxication. 22. The metabolism of phenacetin (p-ethoxyacetanilide) in the rabbit and a further observation on acetanilide metabolismBiochemical Journal, 1949